Financial results - NICO DAVID MED S.R.L.

Financial Summary - Nico David Med S.r.l.
Unique identification code: 34009934
Registration number: J12/189/2015
Nace: 8622
Sales - Ron
109.017
Net Profit - Ron
30.197
Employee
2
The most important financial indicators for the company Nico David Med S.r.l. - Unique Identification Number 34009934: sales in 2023 was 109.017 euro, registering a net profit of 30.197 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nico David Med S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - 22.872 45.116 54.023 67.444 72.937 81.058 98.405 96.802 109.017
Total Income - EUR - 22.872 45.117 54.236 67.448 72.937 81.063 98.417 96.802 109.029
Total Expenses - EUR - 12.944 26.030 35.700 43.001 58.089 55.252 65.084 80.550 77.829
Gross Profit/Loss - EUR - 9.928 19.086 18.536 24.447 14.848 25.811 33.333 16.253 31.200
Net Profit/Loss - EUR - 9.242 18.635 17.996 23.772 14.119 25.056 32.577 15.381 30.197
Employees - 2 2 3 3 3 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 13.0%, from 96.802 euro in the year 2022, to 109.017 euro in 2023. The Net Profit increased by 14.862 euro, from 15.381 euro in 2022, to 30.197 in the last year.

Check the financial reports for the company - Nico David Med S.r.l.

Rating financiar

Financial Rating -
Nico David Med S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Nico David Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nico David Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Nico David Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nico David Med S.r.l. - CUI 34009934

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - 1.038 13.221 9.656 41.848 57.491 48.585 41.035 43.054 47.538
Current Assets - 9.676 20.549 16.651 14.537 23.173 50.534 77.249 32.881 48.131
Inventories - 1.205 0 0 0 0 451 1.578 0 0
Receivables - 3.739 9.517 5.830 9.025 6.560 2.676 10.166 17.554 18.781
Cash - 4.732 11.032 10.821 5.512 16.613 47.407 65.505 15.326 29.350
Shareholders Funds - 9.287 27.828 18.048 41.489 54.804 78.822 109.650 66.258 85.268
Social Capital - 45 45 44 43 42 41 40 41 40
Debts - 1.962 5.943 8.258 14.896 25.859 20.297 8.633 9.677 10.401
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 48.131 euro in 2023 which includes Inventories of 0 euro, Receivables of 18.781 euro and cash availability of 29.350 euro.
The company's Equity was valued at 85.268 euro, while total Liabilities amounted to 10.401 euro. Equity increased by 19.210 euro, from 66.258 euro in 2022, to 85.268 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Nico David Med S.r.l.

Comments - Nico David Med S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.